glp-1 supply news today 2025 Who Gets the Shot? Access by State GLP-1 Agonists Market Report 2025-2033,

The GLP-1 Constipation Timeline: Why It May Last Longer Constipation can be less dramatic than vomiting, but it can become an ongoing quality-of-life problem

Wegovy was developed to help with weight loss

This interaction with SIRT1, a key enzyme in cellular stress response and longevity, opens new research directions

Kidney outcomes with glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, dipeptidyl peptidase-4 inhibitors, and sulfonylureas in type 2 diabetes and moderate cardiovascular risk

For many people, this is a positive benefit, but when you introduce a prescription medication that performs a similar function, the situation becomes more complex

Kidney and cardiovascular outcomes among patients with CKD receiving GLP-1 receptor agonists: a systematic review and meta-analysis of randomized trials